Skip to menu Skip to content Skip to footer

1999

Journal Article

Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability

Biden, Kelli G., Simms, Lisa A., Cummings, Margaret, Buttenshaw, Ron, Schoch, Estelle, Searle, Jeffrey, Gobe, Glenda, Jass, Jeremy R., Meltzer, Stephen J., Leggett, Barbara A. and Young, Joanne (1999). Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability. Oncogene, 18 (5), 1245-1249. doi: 10.1038/sj.onc.1202413

Expression of Bcl-2 protein is decreased in colorectal adenocarcinomas with microsatellite instability

1999

Journal Article

Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro

Walsh, M. D., Luckie, S. M., Cummings, M. C., Antalis, T. M. and McGuckin, M. A. (1999). Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro. Breast Cancer Research & Treatment, 58 (3), 253-264. doi: 10.1023/A:1006345301364

Heterogeneity of MUC1 expression by human breast carcinoma cell lines in vivo and in vitro

1999

Conference Publication

The E-cadherin-catenin system in ovarian cancer

Wright, K., Walsh, M. D., Cummings, M. C. and Chenevix-Trench, G. (1999). The E-cadherin-catenin system in ovarian cancer. 11th Lorne Cancer Conference, Lorne, Victoria, Australia, 11th - 14th February, 1999. Amsterdam: Elsevier.

The E-cadherin-catenin system in ovarian cancer

1999

Journal Article

Improving cervical cytology screening in a remote, high risk population.

Shield, P. W., Nolan, G., Phillips, G. E. and Cummings, M. C. (1999). Improving cervical cytology screening in a remote, high risk population.. Medical Journal of Australia, 170 (6), 255-258.

Improving cervical cytology screening in a remote, high risk population.

1999

Conference Publication

Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator phenotypes

Jass, J. R., Cummings, M. C., Simms, L. A., Walsh, M., Schoch, E., Meltzer, S. J., Wright, C., Searle, J., Young, J. P. and Leggett, B. A. (1999). Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator phenotypes. 11th Lorne Cancer Conference, Lorne, Victoria, Australia, 11th -14th February, 1999.

Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator phenotypes

1999

Conference Publication

The effect of human bile and bile acids on duodenal epithelial cells

Karamatic, R., Donnan, K. D., Cummings, M. C., Winterford, C. M., Young, J. P., Leggett, B. A. and Radford-Smith, G. L. (1999). The effect of human bile and bile acids on duodenal epithelial cells. The Gastroenterological Society of Queensland, Coolum, Queensland, 12th - 14th June, 1999.

The effect of human bile and bile acids on duodenal epithelial cells

1998

Journal Article

Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer

Webb, Penelope M., Green, Adèle, Cummings, Margaret C., Purdie, David M., Walsh, Michael D. and Chenevix-Trench, Georgia (1998). Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. Journal of the National Cancer Institute, 90 (22), 1729-1734. doi: 10.1093/jnci/90.22.1729

Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer

1998

Journal Article

Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers

Simms, Lisa A., Radford-Smith, Graham, Biden, Kelli G., Buttenshaw, Ron, Cummings, Margaret, Jass, Jeremy R., Young, Joanne, Meltzer, Stephen J. and Leggett, Barbara A. (1998). Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers. Oncogene, 17 (15), 2003-2008. doi: 10.1038/sj.onc.1202109

Reciprocal relationship between the tumor suppressors p53 and BAX in primary colorectal cancers

1997

Journal Article

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours

Dong, Y, Walsh, MD, Cummings, MC, Wright, RG, Khoo, SK, Parsons, PG and McGuckin, MA (1997). Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. Journal of Pathology, 183 (3), 311-317. doi: 10.1002/(SICI)1096-9896(199711)183:33.0.CO;2-2

Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours

1997

Journal Article

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

Dong, Y, Walsh, MD, McGuckin, MA, Cummings, MC, Gabrielli, BG, Wright, GR, Hurst, T, Khoo, SK and Parsons, PG (1997). Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer. International Journal of Cancer, 74 (4), 407-415. doi: 10.1002/(SICI)1097-0215(19970822)74:43.0.CO;2-Z

Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer

1997

Journal Article

Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis

Dong, Y., Walsh, M.D., McGuckin, M.A., Gabrielli, B.G., Cummings, M.C., Wright, R.C., Hurst, T., Khoo, S.K. and Parsons, P.G. (1997). Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis. International Journal of Cancer, 74 (1), 57-63. doi: 10.1002/(SICI)1097-0215(19970220)74:13.0.CO;2-F

Increased expression of cyclin-dependent kinase inhibitor 2 (CDKN2A) gene product p16(INK4A) in ovarian cancer is associated with progression and unfavourable prognosis

1997

Journal Article

Apoptosis

Cummings, MC, Winterford, CM and Walker, NI (1997). Apoptosis. American Journal of Surgical Pathology, 21 (1), 88-101. doi: 10.1097/00000478-199701000-00010

Apoptosis

1997

Book Chapter

Apoptosis

Cummings, M. C., Winterford, C. M. and Walker, N. I. (1997). Apoptosis. Histology for pathologists. (pp. 3-21) edited by Stephen S. Sternberg. Philadelphia, PA United States: Lippencott-Raven.

Apoptosis

1996

Journal Article

Increased p53 mRNA expression in liver and kidney apoptosis

Cummings M.C. (1996). Increased p53 mRNA expression in liver and kidney apoptosis. Biochimica et Biophysica Acta - Molecular Basis of Disease, 1315 (2), 100-104. doi: 10.1016/0925-4439(95)00104-2

Increased p53 mRNA expression in liver and kidney apoptosis

1996

Journal Article

Occult axillary node metastases in breast cancer: Their detection and prognostic significance

McGuckin, M. A., Cummings, M. C., Walsh, M. D., Hohn, B. G., Bennett, I. C. and Wright, R. G. (1996). Occult axillary node metastases in breast cancer: Their detection and prognostic significance. British Journal of Cancer, 73 (1), 88-95. doi: 10.1038/bjc.1996.16

Occult axillary node metastases in breast cancer: Their detection and prognostic significance

1995

Journal Article

The feasibility of retrospective grading of breast cancer histology slides derived from multiple pathology services

Cummings, M. C., Wright, R. G., Furnival, C. M., Bain, C. J. and Siskind, V. (1995). The feasibility of retrospective grading of breast cancer histology slides derived from multiple pathology services. The Breast, 4 (3), 179-182. doi: 10.1016/0960-9776(95)90073-X

The feasibility of retrospective grading of breast cancer histology slides derived from multiple pathology services

1993

Journal Article

PCNA immunostaining in breast cancer

Cummings, M. C., Furnival, C. M., Parsons, P. G. and Townsend, E. (1993). PCNA immunostaining in breast cancer. Australian and New Zealand Journal of Surgery, 63 (8), 630-636. doi: 10.1111/j.1445-2197.1993.tb00471.x

PCNA immunostaining in breast cancer